NCT04436042 MyHand 2: An Active Hand Orthosis for Stroke Patients
| NCT ID | NCT04436042 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2020-03-06 |
| Primary Completion | 2028-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2020-03-06 with a primary completion date of 2028-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to further develop and test the hardware and software components of the MyHand device based on user feedback and results from our pilot study. The goal is to refine the device so that is more effective and easier for stroke patients to use to increase their hand function.
Eligibility Criteria
Inclusion Criteria: * Adults over 18 years old * History of stroke(s) with most recent stroke at least six months ago * Upper extremity weakness with impaired ability to complete daily activities with affected hand * Full passive range of motion in all digits * Intact cognition to follow directions * Gross control of proximal upper extremity musculature Exclusion Criteria: * Other neurological conditions besides stroke * Other orthopedic conditions to affected upper extremity * Significant spasticity in affected upper extremity that impairs device fit
Contact & Investigator
Joel Stein, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT04436042 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04436042 currently recruiting?
Yes, NCT04436042 is actively recruiting participants. Contact the research team at ct3351@cumc.columbia.edu for enrollment information.
Where is the NCT04436042 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT04436042 clinical trial?
NCT04436042 is sponsored by Columbia University. The principal investigator is Joel Stein, MD at Columbia University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.